Form 4 Filing for Bristol Myers Squibb Co.

Julia A. Haller, a director at Bristol Myers Squibb Co. (BMY), reported a transaction on June 15, 2026. She exercised an option to acquire 20,460 shares of common stock, with a par value of $0.10, at a price of $53.76 per share. This transaction was a cash exercise, and following the exercise, Ms. Haller directly holds 34,079 shares. The option exercised was for the right to buy common stock, with an expiration date of June 15, 2026. The filing indicates that all shares were exercisable, and the exercise resulted in the acquisition of the underlying shares. This is a reportable transaction under Section 16 of the Securities Exchange Act of 1934.